Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Macrophages promote the progression of premalignant mammary lesions to invasive cancer.

Carron EC, Homra S, Rosenberg J, Coffelt SB, Kittrell F, Zhang Y, Creighton CJ, Fuqua SA, Medina D, Machado HL.

Oncotarget. 2017 Jan 31;8(31):50731-50746. doi: 10.18632/oncotarget.14913. eCollection 2017 Aug 1.

2.

The role of MDM2 and MDM4 in breast cancer development and prevention.

Haupt S, Vijayakumaran R, Miranda PJ, Burgess A, Lim E, Haupt Y.

J Mol Cell Biol. 2017 Feb 1;9(1):53-61. doi: 10.1093/jmcb/mjx007.

3.

Dispersal of an ancient retroposon in the TP53 promoter of Bovidae: phylogeny, novel mechanisms, and potential implications for cow milk persistency.

Dekel Y, Machluf Y, Ben-Dor S, Yifa O, Stoler A, Ben-Shlomo I, Bercovich D.

BMC Genomics. 2015 Feb 5;16:53. doi: 10.1186/s12864-015-1235-8.

4.

TP53 supports basal-like differentiation of mammary epithelial cells by preventing translocation of deltaNp63 into nucleoli.

Munne PM, Gu Y, Tumiati M, Gao P, Koopal S, Uusivirta S, Sawicki J, Wei GH, Kuznetsov SG.

Sci Rep. 2014 Apr 11;4:4663. doi: 10.1038/srep04663.

5.

p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis.

Yallowitz AR, Alexandrova EM, Talos F, Xu S, Marchenko ND, Moll UM.

Cell Death Differ. 2014 Apr;21(4):645-54. doi: 10.1038/cdd.2013.199. Epub 2014 Jan 17.

6.

siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.

Böhringer M, Obermeier K, Griner N, Waldraff D, Dickinson E, Eirich K, Schindler D, Hagen M, Jerry DJ, Wiesmüller L.

Oncogene. 2013 Nov 28;32(48):5458-70. doi: 10.1038/onc.2013.38. Epub 2013 Feb 25.

7.

Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution.

Kumar P, Mukherjee M, Johnson JP, Patel M, Huey B, Albertson DG, Simin K.

PLoS Genet. 2012;8(11):e1003027. doi: 10.1371/journal.pgen.1003027. Epub 2012 Nov 15.

8.

Singleminded-2s (Sim2s) promotes delayed involution of the mouse mammary gland through suppression of Stat3 and NFκB.

Scribner KC, Wellberg EA, Metz RP, Porter WW.

Mol Endocrinol. 2011 Apr;25(4):635-44. doi: 10.1210/me.2010-0423. Epub 2011 Feb 3.

9.

Role of JNK in a Trp53-dependent mouse model of breast cancer.

Cellurale C, Weston CR, Reilly J, Garlick DS, Jerry DJ, Sluss HK, Davis RJ.

PLoS One. 2010 Aug 30;5(8):e12469. doi: 10.1371/journal.pone.0012469.

10.

The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis.

McCready J, Arendt LM, Rudnick JA, Kuperwasser C.

Breast Cancer Res. 2010;12(3):205. doi: 10.1186/bcr2578. Epub 2010 Jun 17. Review.

11.

Skp2B attenuates p53 function by inhibiting prohibitin.

Chander H, Halpern M, Resnick-Silverman L, Manfredi JJ, Germain D.

EMBO Rep. 2010 Mar;11(3):220-5. doi: 10.1038/embor.2010.2. Epub 2010 Feb 5.

12.

Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice.

Yan H, Blackburn AC, McLary SC, Tao L, Roberts AL, Xavier EA, Dickinson ES, Seo JH, Arenas RB, Otis CN, Cao QJ, Lawlor RG, Osborne BA, Kittrell FS, Medina D, Jerry DJ.

Am J Pathol. 2010 Mar;176(3):1421-32. doi: 10.2353/ajpath.2010.090438. Epub 2010 Jan 28.

13.

Dual inactivation of Hus1 and p53 in the mouse mammary gland results in accumulation of damaged cells and impaired tissue regeneration.

Yazinski SA, Westcott PM, Ong K, Pinkas J, Peters RM, Weiss RS.

Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21282-7. doi: 10.1073/pnas.0904965106. Epub 2009 Nov 16.

14.

Mammary involution and breast cancer risk: transgenic models and clinical studies.

Radisky DC, Hartmann LC.

J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):181-91. doi: 10.1007/s10911-009-9123-y. Epub 2009 Apr 30. Review.

15.

Patterns of cell signaling pathway activation that characterize mammary development.

Andrechek ER, Mori S, Rempel RE, Chang JT, Nevins JR.

Development. 2008 Aug;135(14):2403-13. doi: 10.1242/dev.019018. Epub 2008 Jun 11.

16.

Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland.

Wang M, Yu B, Westerlind K, Strange R, Khan G, Patil D, Boeneman K, Hilakivi-Clarke L.

Breast Cancer Res Treat. 2009 May;115(1):213-20. doi: 10.1007/s10549-008-0062-x. Epub 2008 May 31.

17.

Altered mammary gland development in the p53+/m mouse, a model of accelerated aging.

Gatza CE, Dumble M, Kittrell F, Edwards DG, Dearth RK, Lee AV, Xu J, Medina D, Donehower LA.

Dev Biol. 2008 Jan 1;313(1):130-41. Epub 2007 Oct 12.

18.

Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk.

Blackburn AC, Hill LZ, Roberts AL, Wang J, Aud D, Jung J, Nikolcheva T, Allard J, Peltz G, Otis CN, Cao QJ, Ricketts RS, Naber SP, Mollenhauer J, Poustka A, Malamud D, Jerry DJ.

Am J Pathol. 2007 Jun;170(6):2030-41.

19.

p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development.

Yi Y, Shepard A, Kittrell F, Mulac-Jericevic B, Medina D, Said TK.

Mol Biol Cell. 2004 May;15(5):2302-11.

20.

Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?

Blackburn AC, Jerry DJ.

Breast Cancer Res. 2002;4(3):101-11. Epub 2002 Apr 18. Review.

Supplemental Content

Support Center